Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer

Introduction/Background. Nonmetastatic castrate resistant prostate cancer (CRPC) is a challenging disease state. The objective of this study was to evaluate the efficacy and tolerability of bevacizumab in nonmetastatic CRPC patients. Patients. Patients with prostate cancer who developed PSA recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogita, Shin, Tejwani, Sheela, Heilbrun, Lance, Fontana, Joseph, Heath, Elisabeth, Freeman, Stacy, Smith, Daryn, Baranowski, Karen, Vaishampayan, Ulka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382396/
https://www.ncbi.nlm.nih.gov/pubmed/22745916
http://dx.doi.org/10.5402/2012/242850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382396/
https://www.ncbi.nlm.nih.gov/pubmed/22745916
http://dx.doi.org/10.5402/2012/242850

Ejemplares similares